Formyl Peptide Receptor 3 (FPR3) Antibody (HRP)

Este producto es parte de FPR - Formyl Peptide Receptor
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Formyl Peptide Receptor 3 (FPR3) Antibody (HRP)
category
Primary Antibodies
provider
Abbexa
reference
abx336811
tested applications
ELISA

Description

FPR3 Antibody (HRP) is a Rabbit Polyclonal against FPR3.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Formyl Peptide Receptor 3 (FPR3)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
HRP
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P25089
Gene ID
2359
Alias
FPR3,FMLPY,FPRH1,FPRL2,Fprl1 ,Lxa4r,LXA4-R,FPRH2,RMLP-R-I,FMLP-R-II,FML2_HUMAN
Background
Antibody anti-FPR3
Status
RUO

Descripción

FPR3 is a G protein-coupled receptor expressed primarily on monocytes, dendritic cells, and lymphocytes, where it contributes to immune regulation and inflammation. Unlike FPR1 and FPR2, FPR3 has lower affinity for formylated peptides and is more associated with endogenous ligands, playing a role in immune cell migration and immune surveillance. FPR3 localizes primarily to intracellular compartments, suggesting a role in regulating immune responses through intracellular signaling and peptide degradation. It modulates chemotactic responses, dendritic cell maturation, and cytokine production, balancing pro-inflammatory and homeostatic functions. Dysregulation of FPR3 signaling has been implicated in immune disorders and chronic inflammation, where impaired immune cell trafficking can lead to dysfunctional responses. In cancer, FPR3 may contribute to immune evasion and tumor progression, although its role remains less defined compared to FPR1 and FPR2. Targeting FPR3 offers potential for therapies aimed at fine-tuning immune responses, particularly in conditions involving inflammation and immune regulation. Overall, FPR3 acts as a modulator of immune cell function and homeostasis.

Related Products

abx015243

Formyl Peptide Receptor-Like 2 (FPRL2) Antibody

Rabbit polyclonal antibody against FPRL2 protein. Immunogen region is C-terminal.

Ver Producto
abx027122

Formyl Peptide Receptor 3 (FPR3) Antibody

Low affinity receptor for N-formyl-methionyl peptides, which are powerful neutrophils chemotactic factors. Binding of FMLP to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system.

Ver Producto
abx034108

Formyl Peptide Receptor-Like 2 (FPRL2) Antibody

Low affinity receptor for N-formyl-methionyl peptides, which are powerful neutrophils chemotactic factors. Binding of FMLP to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system.

Ver Producto